Product Description
This product is a combined antimalarial therapy containing Sulfadoxine/Pyrimethamine and Amodiaquine.
Sulfadoxine and Pyrimethamine work together to block folic acid synthesis in malaria parasites, inhibiting their growth and replication. Amodiaquine interferes with parasitic heme metabolism, rapidly eliminating plasmodium.
The two components produce strong synergistic effect, raising cure rates, reducing treatment failure, suppressing malaria recurrence and slowing the development of drug resistance.
Indications
For the treatment of uncomplicated malaria caused by susceptible Plasmodium falciparum and other Plasmodium species.
Directions for Use
Oral administration, swallow whole with water. Take exactly as prescribed by a physician or health professional. Do not interrupt the course or adjust dose on your own.
Key Features
- Fixed-dose combination antimalarial
- Synergistic fast parasite clearance
- Low recurrence and reduced drug resistance risk
- Convenient once-course oral tablet
- Good safety and tolerability
Storage
Store in a cool, dry place, sealed, away from direct sunlight and moisture.
Warnings
- Contraindicated in patients hypersensitive to sulfonamides, pyrimethamine, amodiaquine or tablet excipients.
- Use with caution in liver, renal impairment and blood disorder patients.
- Not recommended in first trimester pregnancy without medical assessment.
- Do not use for prolonged periods or exceed recommended dose.
- Keep out of reach of children.
